Hin Sang Group (International) Holding Co. Ltd. (HK:6893)
:6893
Want to see HK:6893 full AI Analyst Report?
6893 Stock Chart & Stats
HK$0.28
HK$0.03(15.04%)
At close: 4:00 PM EST
HK$0.28
HK$0.03(15.04%)
Day’s Range― - ―
52-Week RangeHK$0.02 - HK$0.35
Previous CloseN/A
Volume2.00K
Average Volume (3M)146.87K
Market Cap
HK$139.75M
Enterprise ValueHK$443.10M
Total Cash (Recent Filing)HK$19.87M
Total Debt (Recent Filing)HK$344.41M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Jun 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,091,796,000
10 Day Avg. Volume47,000
30 Day Avg. Volume146,866
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)1.46
Price to Sales (P/S)2.47
P/FCF Ratio-53.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendSustained revenue growth (~10.4%) indicates expanding top-line demand for the company's products. Over a 2-6 month horizon this growth supports the potential for scale economies and revenue-driven margin improvement if operating costs are controlled, underpinning medium-term recovery prospects.
Gross Margin HealthA relatively healthy gross margin implies the core product economics are sound and the business can generate markup on sales. This structural margin strength gives management scope to restore profitability by cutting operating expenses or improving SG&A efficiency over several months.
Moderate Equity RatioA moderate equity ratio provides a basic capital buffer versus an all-debt structure. While leverage is elevated, this equity base offers some asset financing stability and modest flexibility for refinancing or absorbing shocks without immediate erosion of solvency.
Bears Say
Ongoing UnprofitabilityPersistent net losses and negative EBIT/EBITDA undermine internal funding capacity and erode shareholder equity. Over months this reduces strategic options, forces reliance on external capital, and makes achieving sustained profitability more challenging without structural cost or revenue fixes.
High LeverageA debt-to-equity ratio above 2 creates significant financial strain: higher interest expense, tighter covenant risk, and constrained investment ability. This elevated leverage is a durable vulnerability that limits operational flexibility and increases default risk if cash generation doesn’t improve.
Weak Cash GenerationNegative free cash flow growth and weak operating cash conversion mean the company cannot internally fund operations or debt service sustainably. This structural cash shortfall likely necessitates external financing, pressuring margins and strategic initiatives over the medium term.
Hin Sang Group (International) Holding Co. Ltd. News
6893 FAQ
What was Hin Sang Group (International) Holding Co. Ltd.’s price range in the past 12 months?
Hin Sang Group (International) Holding Co. Ltd. lowest stock price was HK$0.02 and its highest was HK$0.35 in the past 12 months.
What is Hin Sang Group (International) Holding Co. Ltd.’s market cap?
Hin Sang Group (International) Holding Co. Ltd.’s market cap is HK$139.75M.
When is Hin Sang Group (International) Holding Co. Ltd.’s upcoming earnings report date?
Hin Sang Group (International) Holding Co. Ltd.’s upcoming earnings report date is Jun 25, 2026 which is in 57 days.
How were Hin Sang Group (International) Holding Co. Ltd.’s earnings last quarter?
Hin Sang Group (International) Holding Co. Ltd. released its earnings results on Nov 27, 2025. The company reported -HK$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.009.
Is Hin Sang Group (International) Holding Co. Ltd. overvalued?
According to Wall Street analysts Hin Sang Group (International) Holding Co. Ltd.’s price is currently Overvalued.
Does Hin Sang Group (International) Holding Co. Ltd. pay dividends?
Hin Sang Group (International) Holding Co. Ltd. pays a Quarterly dividend of HK$0.01 which represents an annual dividend yield of N/A. See more information on Hin Sang Group (International) Holding Co. Ltd. dividends here
What is Hin Sang Group (International) Holding Co. Ltd.’s EPS estimate?
Hin Sang Group (International) Holding Co. Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hin Sang Group (International) Holding Co. Ltd. have?
Hin Sang Group (International) Holding Co. Ltd. has 1,091,796,000 shares outstanding.
What happened to Hin Sang Group (International) Holding Co. Ltd.’s price movement after its last earnings report?
Hin Sang Group (International) Holding Co. Ltd. reported an EPS of -HK$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.923%.
Which hedge fund is a major shareholder of Hin Sang Group (International) Holding Co. Ltd.?
Currently, no hedge funds are holding shares in HK:6893
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hin Sang Group (International) Holding Co. Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-27.00%
Trailing 12-Months
Asset Growth
-10.23%
Trailing 12-Months
Company Description
Hin Sang Group (International) Holding Co. Ltd.
Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.
Hin Sang Group (International) Holding Co. Ltd. (6893) Earnings & Revenues
Technical Analysis
Fourace Industries Group Holdings Limited
―
Evergreen Products Group Ltd.
―
China Ludao Technology Co. Ltd.
―
Nanjing Sinolife United Co., Ltd. Class H
―